Literature DB >> 24117999

Gastro 2013 APDW/WCOG Shanghai working party report: chronic diarrhea: definition, classification, diagnosis.

Lawrence R Schiller1, Darrell S Pardi, Robin Spiller, Carol E Semrad, Christina M Surawicz, Ralph A Giannella, Guenter J Krejs, Michael J G Farthing, Joseph H Sellin.   

Abstract

Diarrhea is best defined as passage of loose stools often with more frequent bowel movements. For clinical purposes, the Bristol Stool Form Scale works well to distinguish stool form and to identify loose stools. Laboratory testing of stool consistency has lagged behind. Acute diarrhea is likely to be due to infection and to be self-limited. As diarrhea becomes chronic, it is less likely to be due to infection; duration of 1 month seems to work well as a cut-off for chronic diarrhea, but detailed scientific knowledge is missing about the utility of this definition. In addition to duration of diarrhea, classifications by presenting scenario, by pathophysiology, and by stool characteristics (e.g. watery, fatty, or inflammatory) may help the canny clinician refine the differential diagnosis of chronic diarrhea. In this regard, a careful history remains the essential part of the evaluation of a patient with diarrhea. Imaging the intestine with endoscopy and radiographic techniques is useful, and biopsy of the small intestine and colon for histological assessment provides key diagnostic information. Endomicroscopy and molecular pathology are only now being explored for the diagnosis of chronic diarrhea. Interest in the microbiome of the gut is increasing; aside from a handful of well-described infections because of pathogens, little is known about alterations in the microbiome in chronic diarrhea. Serological tests have well-defined roles in the diagnosis of celiac disease but have less clearly defined application in autoimmune enteropathies and inflammatory bowel disease. Measurement of peptide hormones is of value in the diagnosis and management of endocrine tumors causing diarrhea, but these are so rare that these tests are of little value in screening because there will be many more false-positives than true-positive results. Chemical analysis of stools is of use in classifying chronic diarrhea and may limit the differential diagnosis that must be considered, but interpretation of the results is still evolving. Breath tests for assessment of carbohydrate malabsorption, small bowel bacterial overgrowth, and intestinal transit are fraught with technical limitations that decrease sensitivity and specificity. Likewise, tests of bile acid malabsorption have had limited utility beyond empirical trials of bile acid sequestrants.
© 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  clinical intestinal disorders < gastroenterology; diarrhea and malabsorption < gastroenterology; intestinal disorders < gastroenterology

Mesh:

Substances:

Year:  2014        PMID: 24117999     DOI: 10.1111/jgh.12392

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  20 in total

Review 1.  Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea.

Authors:  Michael Camilleri; Joseph H Sellin; Kim E Barrett
Journal:  Gastroenterology       Date:  2016-10-20       Impact factor: 22.682

2.  Gastrointestinal complications in renal transplant recipients detected by endoscopic biopsies in a developing country.

Authors:  Muhammed Ishaque; Rahma Rashid; Muhammed Mubarak
Journal:  Indian J Gastroenterol       Date:  2015-03-12

3.  How to manage chronic diarrhoea in the elderly?

Authors:  Benjamin Crooks; Jimmy K Limdi; John McLaughlin
Journal:  Frontline Gastroenterol       Date:  2019-04-29

Review 4.  Antidiarrheal Drug Therapy.

Authors:  Lawrence R Schiller
Journal:  Curr Gastroenterol Rep       Date:  2017-05

5.  Demographic and Dietary Associations of Chronic Diarrhea in a Representative Sample of Adults in the United States.

Authors:  Prashant Singh; Shuji Mitsuhashi; Sarah Ballou; Vikram Rangan; Thomas Sommers; Vivian Cheng; Johanna Iturrino-Moreda; Daniel Friedlander; Judy Nee; Anthony Lembo
Journal:  Am J Gastroenterol       Date:  2018-03-06       Impact factor: 10.864

6.  Acupuncture for chronic diarrhea in adults: Protocol for a systematic review.

Authors:  Zongshi Qin; Bo Li; Jiani Wu; Jinhui Tian; Shang Xie; Zhi Mao; Jing Zhou; Tae-Hun Kim; Zhishun Liu
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

Review 7.  Severe enteropathy with villous atrophy in prolonged mefenamic acid users - a currently under-recognized in previously well-recognized complication: Case report and review of literature.

Authors:  Uayporn Kaosombatwattana; Julajak Limsrivilai; Ananya Pongpaibul; Monthira Maneerattanaporn; Phunchai Charatcharoenwitthaya
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

8.  Effectiveness of three commonly used transition phase diets in the inpatient management of children with severe acute malnutrition: a pilot randomized controlled trial in Malawi.

Authors:  Christian J Versloot; Wieger Voskuijl; Sara J van Vliet; Meta van den Heuvel; Jane C Carter; Ajib Phiri; Marko Kerac; Geert Tom Heikens; Patrick F van Rheenen; Robert H J Bandsma
Journal:  BMC Pediatr       Date:  2017-04-26       Impact factor: 2.125

9.  Development of a Score to Predict Positive Colonic Histology in Chronic Diarrhea Assessed in Open-access Colonoscopy.

Authors:  Jessica Atieh; Victor Chedid; Katayoun Khoshbin; Sunanda Kane; Michael Camilleri
Journal:  J Clin Gastroenterol       Date:  2021-09-01       Impact factor: 3.174

10.  Electroacupuncture for patients with diarrhea-predominant irritable bowel syndrome or functional diarrhea: A randomized controlled trial.

Authors:  Hui Zheng; Ying Li; Wei Zhang; Fang Zeng; Si-Yuan Zhou; Hua-Bin Zheng; Wen-Zeng Zhu; Xiang-Hong Jing; Pei-Jing Rong; Chun-Zhi Tang; Fu-Chun Wang; Zhi-Bin Liu; Shi-Jun Wang; Mei-Qi Zhou; Zhi-Shun Liu; Bing Zhu
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.